Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit

NCT02686411 | Completed

• 2 other identifiers: 2015-1074NCI-2020-11433
• Study Type: observational
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

This study examines the difference between the quality of care patients receive with palliative care consult services and the palliative care unit. This may help researchers learn how improvements can be made to the level of care provided in the palliative care unit and improve satisfaction with quality of care by patients and caregivers.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (4)

• Relative satisfaction rate

  Defined as the percentage of patients that answered "Better" and "Much Better" to the first question in the global rating on "overall care". The relative satisfaction rate after palliative care unit (PCU) care in patients or caregivers will be estimated with 95% confidence interval.

  through study completion, an average of 1 year

• Patient Global Survey/Caregiver Global Survey

  Assessed by Edmonton Symptom Assessment Scale (ESAS), Memorial Delirium Assessment Scale (MDAS) distress thermometer will be summarized by descriptive analysis and/or tabulation.

  through study completion, an average of 1 year

• Distress thermometer

  Measured by Family Satisfaction with end-of-life care will be summarized descriptively for each time point and may be compared within patients and within caregivers before and after the PCU by Wilcoxon signed-rank test, when the outcome is on Likert ordinal scales with 3, 5 levels or even 10 levels and the differences in the scales can be considered as continuous variables.

  through study completion, an average of 1 year

• Patients' and caregivers' opinions on quality of care

  Measured by Family Satisfaction with end-of-life care will be summarized descriptively for each time point and may be compared within patients and within caregivers before and after the PCU by Wilcoxon signed-rank test, when the outcome is on Likert ordinal scales with 3, 5 levels or even 10 levels and the differences in the scales can be considered as continuous variables.

  through study completion, an average of 1 year

Study Arms (1)

Observational (survey)

Patients and caregivers complete surveys over 5-10 minutes before and after care in the PCU.

Other: Survey Administration

Interventions

Survey Administration OTHER

Complete survey

Observational (survey)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients and/or patients' caregivers who have completed at least 2 weekdays on an in-patient service together

You may qualify if:

• Patients and/or patients' caregivers who have completed at least 2 weekdays on an in-patient service together with the assistance of the palliative care consult services (PCCS), and who then are transitioned to the care of the PCU team along with an admission order to that effect
• A caregiver (if participating) must have been present with the patient during 2 weekdays on the inpatient service and present for at least 2 weekdays of care on the PCU
• Both patient and caregiver participation is optional but both must be 18 years of age or older
• A caregiver will be defined by the patient as "the person most involved with their care". However, if the patient lacks capacity, the caregiver will be decided via discussion with individuals indicated in the patient's Medical Power of Attorney or the Texas rule of law if this is not present
• Both patient and caregiver (if participating) must understand, read and speak English
• Both patient (if actively participating) and caregiver (if participating) must sign an informed consent form

You may not qualify if:

• Patients or caregivers with physical limitations (visual or motor impairment) causing inability to read, complete or sign the consent form and surveys after considering appropriate aid and assistance
• Patients or caregivers who the research staff, bedside nurse, or palliative care physician or mid-level provider deems unable to participate due to poor cognitive capacity or acute physical distress
• Caregivers who are not able to attend the patient for at least 2 weekdays while on the PCU
• Patients who are imminently dying as determined by the palliative physician (or designated advanced practice provider \[APP\]/fellow)

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Officials

• Ahsan Azhar

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 17, 2016
• First Posted: February 19, 2016
• Study Start: February 17, 2016
• Primary Completion: April 29, 2022
• Study Completion: April 29, 2022
• Last Updated: May 10, 2022

Record last verified: 2022-05

Locations

US (1)